Filing metadata

Accession number
0001169245-21-000014
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
Feb 09, 2021
Reporting period
Feb 05, 2021
Description
Insider transaction

Explore SEC Filings Hub